Prof. Thomas Leung Yun-chung, Professor of PolyU’s Department of Applied Biology and Chemical Technology and Prof. Alisa Shum Sau-wun, Associate Professor of the School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK), have developed a first-in-class drug, ABarginase, for treatment of multiple obesity-related metabolic diseases. The drug is an albumin-binding recombinant human arginase that is engineered using an advanced fusion protein strategy. This allows for an inexpensive and highly efficient fabrication process, making ABarginase affordable and widely adoptable for clinical applications. (Oriental Daily News A04, Hong Kong Economic Journal A08, Hong Kong Economic Times A14, Sky Post P05, Ta Kung Pao A08, Wen Wei Po A06, Lion Rock Daily P01)
Press release:
English | Chinese
Online coverage:
| TVB | https://polyu.me/3BME1oI |
| Now TV | https://polyu.me/3ITxVa7 |
| i-Cable | https://polyu.me/43ipRY5 |
| RTHK | |
| Metro Radio | https://polyu.me/3WnA3wd |
| AM730 | https://polyu.me/45lSpSk |
| Ming Pao Daily News | https://polyu.me/3OyojoF |
| Oriental Daily News | https://polyu.me/3MLmSSp |
| Hong Kong Economic Journal | https://polyu.me/3OvqIR9 (subscription required) |
| Sky Post | https://polyu.me/3od1FHS |
| Ta Kung Pao | https://polyu.me/42TyY1u |
| Wen Wei Po | https://polyu.me/3MMrCr2 |
| China Daily (Hong Kong Edition) | https://polyu.me/3q38coY |
| Bastille Post | https://polyu.me/3pZAqkn |
| Dot Dot News |
https://polyu.me/3OumXLy |
| Line Today | https://polyu.me/43dtcYo |
| Medical Express | https://polyu.me/3IyHH11 |
| Mirage News | https://polyu.me/3pRYh5p |
| Yahoo HK | https://polyu.me/3pWbUR7 |
